References
- Kislaya I, Goncalves P, Gómez V, et al. SARS-CoV-2 seroprevalence in Portugal following the third epidemic wave: results of the second National Serological Survey (ISN2COVID-19). Infect Dis. 2022;2022:1–7.
- Olariu TR, Lighezan R, Ursoniu S, et al. Seroprevalence of SARS-CoV-2 antibodies in 2115 blood donors from Romania. Clin Microbiol Infect. 2021;27(5):817–819.
- Ministerul Sănătăţii Publice din Romania ORDIN Nr. 1193 din 7 iulie 2007 pentru aprobarea normelor privind informaţiile care trebuie oferite donatorilor de sânge şi de componente sanguine de origine umană, precum şi informaţiile care trebuie comunicate de către donatori la fiecare donare şi admisibilitatea donatorilor de sânge şi de componente sanguine umane. (Romanian Ministry of Public Health. ORDER Nr. 1193 of July 7, 2007 for the approval of the rules on the information to be provided to donors of blood and blood components of human origin, as well as the information to be communicated by donors at each donation and the admissibility of donors of human blood and blood components); [cited 2007 Feb 23]. Available from: http://www.lexmed.ro/doc/Ordin_1193_2007.pdf. (in Romanian)
- Bradley T, Grundberg E, Selvarangan R, et al. Antibody responses after a single dose of SARS-CoV-2 mRNA vaccine. N Engl J Med. 2021;384(20):1959–1961.
- Yau K, Abe KT, Naimark D, et al. Evaluation of the SARS-CoV-2 antibody response to the BNT162b2 vaccine in patients undergoing hemodialysis. JAMA Netw Open. 2021;4(9):e2123622.
- Schoenhals M, Rabenindrina N, Rakotondramanga JM, et al. SARS-CoV-2 antibody seroprevalence follow-up in malagasy blood donors during the 2020 COVID-19 epidemic. EBioMedicine. 2021;68:103419.
- Uyoga S, Adetifa IMO, Otiende M, et al. Prevalence of SARS-CoV-2 antibodies from a national serosurveillance of kenyan blood donors. JAMA. 2021;2021:e2115265.
- Weidner L, Nunhofer V, Jungbauer C, et al. Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors. Infection. 2021;49(6):1187–1188.
- Hvalryg M, Nissen-Meyer LSH. Sero-prevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Norway, winter/spring 2021. Transfus Apher Sci. 2021;60(5):103256.
- Perreault J, Tremblay T, Fournier MJ, et al. Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset. Blood. 2020;136(22):2588–2591.